Gigantol attenuates the proliferation of human liver cancer HepG2 cells through the PI3K/Akt/NF-κB signaling pathway

Oncology Reports

Volumn 37, Issue 2, 2017, Pages 865-870

  Chen, Huanhuan ^a   Huang, Yuechun ^a   Huang, Junbin ^a   Lin, Lizhen ^a   Wei, Gang ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Apoptosis; Gigantol; Human liver cancer; PI3K Akt NF B pathway

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; GIGANTOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; BIBENZYL DERIVATIVE; GUAIACOL;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; GROWTH INHIBITION; HEP-G2 CELL LINE; HUMAN; HUMAN CELL; LIVER CANCER; MORPHOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DRUG EFFECTS; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE;

APOPTOSIS; BIBENZYLS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; FLOW CYTOMETRY; GUAIACOL; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; TUMOR CELLS, CULTURED;

EID: 85011851623     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2016.5299     Document Type: Article

References (33)

1. Yu F, Shen X, Fan L and Yu Z: Analysis of histone modifications at human ribosomal DNA in liver cancer cell. Sci Rep 5: 18100, 2015.
2. Bosch FX, Ribes J, Díaz M and Cléries R: Primary liver cancer: Worldwide incidence and trends. Gastroenterology 127 (Suppl 1): S5-S16, 2004.
3. Palliyaguru DL and Wu F: Global geographical overlap of aflatoxin and hepatitis C: Controlling risk factors for liver cancer worldwide. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 30: 534-540, 2013.
4. Lin L, Fang Z, Lin H, You H, Wang J, Su Y, Wang F and Zhang ZY: Depletion of Cks1 and Cks2 expression compromises cell proliferation and enhance chemotherapy-induced apoptosis in HepG2 cells. Oncol Rep 35: 26-32, 2016.
5. Zeng J, Chen S, Li N, Chen L, Su J, Niu G, Zhu S and Liang Y: Sasanquasaponin from Camellia oleifera Abel. induces apoptosis via Bcl-2, Bax and caspase-3 activation in HepG2 cells. Mol Med Rep 12: 1997-2002, 2015.
6. Shi JJ, Jia XL, Li M, Yang N, Li YP, Zhang X, Gao N and Dang SS: Guggulsterone induces apoptosis of human hepatocellular carcinoma cells through intrinsic mitochondrial pathway. World J Gastroenterol 21: 13277-13287, 2015.
7. Zhao X, Jiang K, Liang B and Huang X: Anticancer effect of xanthohumol induces growth inhibition and apoptosis of human liver cancer through NF-κB/p53-apoptosis signaling pathway. Oncol Rep 35: 669-675, 2016.
8. Shu G, Yue L, Zhao W, Xu C, Yang J, Wang S and Yang X: Isoliensinine, a bioactive alkaloid derived from embryos of Nelumbo nucifera, induces hepatocellular carcinoma cell apoptosis through suppression of NF-κB signaling. J Agric Food Chem 63: 8793-8803, 2015.
9. Yang L, Wang Z and Xu L: Phenols and a triterpene from Dendrobium aurantiacum var. denneanum (Orchidaceae). Biochem Syst Ecol 34: 658-660, 2006.
10. Rodrigues S, Calhelha RC, Barreira JCM, Dueñas M, Carvalho AM, Abreu RMV, Buelga CS and Ferreira ICFR: Crataegus monogyna buds and fruits phenolic extracts: Growth inhibitory activity on human tumor cell lines and chemical characterization by HPLC?DAD?ESI/MS. Food Res Int 49: 516-523, 2012.
11. Fang H, Hu X, Wang M, Wan W, Yang Q, Sun X, Gu Q, Gao X, Wang Z, Gu L, et al: Anti-osmotic and antioxidant activities of gigantol from Dendrobium aurantiacum var. denneanum against cataractogenesis in galactosemic rats. J Ethnopharmacol 172: 238-246, 2015.
12. Bhummaphan N and Chanvorachote P: Gigantol suppresses cancer stem cell-like phenotypes in lung cancer cells. Evid-Based Compl Al 2015: 1-10, 2015.
13. Miyazawa M, Shimamura H, Nakamura S and Kameoka H: Antimutagenic activity of gigantol from Dendrobium nobile. J Agric Food Chem 45: 2849-2853, 1997.
14. Won JH, Kim JY, Yun KJ, Lee JH, Back NI, Chung HG, Chung SA, Jeong TS, Choi MS and Lee KT: Gigantol isolated from the whole plants of Cymbidium goeringii inhibits the LPS-induced iNOS and COX-2 expression via NF-κB inactivation in RAW 264.7 macrophages cells. Planta Med 72: 1181-1187, 2006.
15. Wu J, Lu C, Li X, Fang H, Wan W, Yang Q, Sun X, Wang M, Hu X, Chen CY, et al: Synthesis and biological evaluation of novel gigantol derivatives as potential agents in prevention of diabetic cataract. PLoS One 10: e0141092, 2015.
16. Song G, Ouyang G and Bao S: The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9: 59-71, 2005.
17. Rychahou PG, Jackson LN, Silva SR, Rajaraman S and Evers BM: Targeted molecular therapy of the PI3K pathway: Therapeutic significance of PI3K subunit targeting in colorectal carcinoma. Ann Surg 243: 833-842, 2006.
18. Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30: 193-204, 2004.
19. Xin M and Deng X: Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J Biol Chem 280: 10781-10789, 2005.
20. Dey A, Tergaonkar V and Lane DP: Double-edged swords as cancer therapeutics: Simultaneously targeting p53 and NF-κB pathways. Nat Rev Drug Discov 7: 1031-1040, 2008.
21. Chariot A: The NF-κB-independent functions of IKK subunits in immunity and cancer. Trends Cell Biol 19: 404-413, 2009.
22. Kim SM, Lee SY, Yuk DY, Moon DC, Choi SS, Kim Y, Han SB, Oh KW and Hong JT: Inhibition of NF-κB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Arch Pharm Res 32: 755-765, 2009.
23. Maddika S, Ande SR, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, Eshraghi M, Manda KD, Wiechec E and Los M: Cell survival, cell death and cell cycle pathways are interconnected: Implications for cancer therapy. Drug Resist Updat 10: 13-29, 2007.
24. Hu Q, Pan R, Wang L, Peng B, Tang J and Liu X: Platycodon grandiflorum induces apoptosis in SKOV3 human ovarian cancer cells through mitochondrial-dependent pathway. Am J Chin Med 38: 373-386, 2010.
25. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B and Reutelingsperger CP: Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31: 1-9, 1998.
26. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT and Willems GM: Binding of vascular anticoagulant α (VACα) to planar phospholipids bilayers. Blood Coagul Fibrinolysis 5: 921-928, 1994.
27. Stambolic V and Woodgett JR: Functional distinctions of protein kinase B/Akt isoforms defined by their influence on cell migration. Trends Cell Biol 16: 461-466, 2006.
28. Kim HJ, Kim JC, Min JS, Kim MJ, Kim JA, Kor MH, Yoo HS and Ahn JK: Aqueous extract of Tribulus terrestris Linn induces cell growth arrest and apoptosis by down-regulating NF-κB signaling in liver cancer cells. J Ethnopharmacol 136: 197-203, 2011.
29. Azijli K, Weyhenmeyer B, Peters GJ, de Jong S and Kruyt FA: Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: Discord in the death receptor family. Cell Death Differ 20: 858-868, 2013.
30. Shan RF, Zhou YF, Peng AF and Jie ZG: Inhibition of Aurora-B suppresses HepG2 cell invasion and migration via the PI3K/Akt/NF-κB signaling pathway in vitro. Exp Ther Med 8: 1005-1009, 2014.
31. Booth L, Cruickshanks N, Ridder T, Dai Y, Grant S and Dent P: PARP and CHK inhibitors interact to cause DNA damage and cell death in mammary carcinoma cells. Cancer Biol Ther 14: 458-465, 2013.
32. Kulkarni A, Oza J, Yao M, Sohail H, Ginjala V, Tomas-Loba A, Horejsi Z, Tan AR, Boulton SJ and Ganesan S: Tripartite motif-containing 33 (TRIM33) protein functions in the poly(ADP-ribose) polymerase (PARP)-dependent DNA damage response through interaction with Amplified in Liver Cancer 1 (ALC1) protein. J Biol Chem 288: 32357-32369, 2013.
33. Brown CJ, Lain S, Verma CS, Fersht AR and Lane DP: Awakening guardian angels: Drugging the p53 pathway. Nat Rev Cancer 9: 862-873, 2009.